Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461876 · ClinicalTrials.gov registry record
Obesity in HIV After Antiretroviral Therapy
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 200
- Enrollment target
NCT01461876 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 200 participants.
The verdict
NCT01461876 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This is a retrospective longitudinal study that evaluates the prevalence and incidence of overweight/obesity within an HIV-infected population before and after 12 and 24 months of a stable antiretroviral therapy (ART). The study group will be compared to the weight of a healthy, matched population that is not infected with HIV. The primary hypothesis states that the proportion of HIV-infected persons newly classified as overweight/obese will increase by ≥20% after 12 months of initial ART, and this incidence will be greater than that of a matched HIV-uninfected control population. The effect of immune function variables, such as CD4, HIV viral load, and ART regimen on weight will be analyzed. In addition, the study will analyze the effect of weight and immune function markers on the inflammatory markers, high sensitivity C-reactive protein (hsCRP) and D-dimer. An HIV samples repository will be used for specimens to be assayed for hsCRP and D-dimer.
Interventions
- DRUG antiretroviral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01461876
The ClinicalTrials.gov registry entry for NCT01461876 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which antiretroviral therapy is the first listed.
NCT01461876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01461876 about?
NCT01461876 is a clinical study titled "Obesity in HIV After Antiretroviral Therapy". This is a retrospective longitudinal study that evaluates the prevalence and incidence of overweight/obesity within an HIV-infected population before and after 12 and 24 months of a stable antiretroviral therapy (ART). The study group will be compared to the weight of a healthy, matched population t...
What is the current status of trial NCT01461876?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2009-11. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01461876?
The interventions under investigation include: antiretroviral therapy (DRUG).
Who is sponsoring clinical trial NCT01461876?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.